Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
Items 601–700 of 1,002
An, L., Adeli, E., Liu, M., Zhang, J., Lee, S.-W., & Shen, D. (2017) · Scientific Reports · doi:10.1038/srep45269 · Cited by 39
“It has been reported that gender 45,46 and race 47,48 are important factors in AD studies.”
BackgroundSuicide Among Persons With Dementia, Georgia, 2013 to 2016
Annor, F., Bayakly, R. A., Morrison, R. A., Bryan, M., Gilbert, L. K., Ivey-Stephenson, A. Z., Holland, K. M., & Simon, T. R. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718814363 · Cited by 40
“Alzheimer’s disease is the most common form of dementia in the United States, accounting for about 70% of all cases.(7) It is estimated that nearly 10% of Americans (representing 5.”
InfluentialPhysical activity modifies the association between depression and cognitive function in older adults
Hu, L., Smith, L., Imm, K. R., Jackson, S. E., & Yang, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.008 · Cited by 45
State of the Science Burn Research: Burns in the Elderly
Jeschke, M. G., Phelan, H. A., Wolf, S. C., Romanowski, K. S. S., Rehou, S., Saetamal, A., Weber, J., Schulz, J., New, C., Wiktor, A. J., et al. (2020) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz163 · Cited by 43
Harding, B. N., Floyd, J. S., Scherrer, J. F., Salas, J., Morley, J. E., Farr, S. A., & Dublin, S. (2020) · Healthcare · doi:10.1016/j.hjdsi.2020.100430 · Cited by 42
Thapa, N., Kim, B., Yang, J., Park, H.-J., Jang, M., Son, H., Kim, G.-M., & Park, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103701 · Cited by 44
“It leads to a gradual decline in independent function, affecting not only the individual but also their family and healthcare system [2].”
BackgroundGeriatric Assessment in Older Patients with Breast Cancer
Klepin, H. D., Mohile, S. G., & Hurria, A. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0016 · Cited by 42
“The prevalence increases to 25% to 48% in samples of community-living populations older than 80 years.(40) The prevalence of early or mild cognitive impairment is estimated to be even higher.”
BackgroundImpact of Comorbid Dementia on Patterns of Hospice Use
Aldridge, M. D., Hunt, L., Husain, M., Li, L., & Kelley, A. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0055 · Cited by 39
Long-term use of tamoxifen reduces the risk of dementia: A nationwide population-based cohort study
Sun, L.-M., Chen, H.-J., Liang, J.-A., & Kao, C.-H. (2016) · QJM · doi:10.1093/qjmed/hcv072 · Cited by 39
Coleman, M. E., Roessler, M., Peng, S., Roth, A. R., Risacher, S. L., Saykin, A. J., Apostolova, L. G., & Perry, B. L. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13035 · Cited by 41
Liu, Y.-W., He, Y.-H., Zhang, Y.-X., Cai, W.-W., Yang, L.-Q., Xu, L.-Y., & Kong, Q.-P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.023 · Cited by 39
“9% of the dementia that is prevalent in persons older than 60 years (Plassman et al., 2007).”
BackgroundTraits of patients who screen positive for dementia and refuse diagnostic assessment
Fowler, N. R., Frame, A., Perkins, A. J., Gao, S., Watson, D. P., Monahan, P. O., & Boustani, M. A. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.01.002 · Cited by 39
Jhan, J., Yang, Y., Chang, Y.-H., Guu, S., & Tsai, C.-C. (2017) · The Aging Male · doi:10.1080/13685538.2016.1271782 · Cited by 40
“of dementia, accounting for more than 50% of all cases [6].”
BackgroundAdvance Directives among Nursing Home Residents with Mild, Moderate, and Advanced Dementia
Tjia, J., Dharmawardene, M., & Givens, J. L. (2017) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0473 · Cited by 39
“1 As this population continues to grow, 2–4 it is increasingly important to understand and routinely document patient preferences regarding medical decision making and end-of-life care planning.”
Henderson, Y. O., Bithi, N., Link, C., Yang, J., Schugar, R. C., Llarena, N. C., Brown, J. M., & Hine, C. (2021) · GeroScience · doi:10.1007/s11357-021-00330-4 · Cited by 39
Penfold, R. B., Carrell, D., Cronkite, D., Pabiniak, C. J., Dodd, T., Glass, A. M., Johnson, E., Thompson, E., Arrighi, H. M., & Stang, P. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01864-z · Cited by 43
“The U.S. population is aging and age-related diseases like Alzheimer’s Disease and related dementias (ADRD) are becoming more prevalent [1, 2].”
BackgroundHescham, S., Jahanshahi, A., Mériaux, C., Lim, L. W., Blokland, A., & Temel, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.032 · Cited by 43
The Management of Sleep and Circadian Disturbance in Patients with Dementia
Zhou, Q. P., Jung, L., & Richards, K. C. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0249-8 · Cited by 41
Walsh, J. N., Manor, B. D., Hausdorff, J. M., Novak, V., Lipsitz, L. A., Gow, B. J., Macklin, E. A., Peng, C., & Wayne, P. M. (2015) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2015.058 · Cited by 41
“Community-dwelling Healthy Adults Inclusion criteria were (1) age of 50 years to 79 years and (2) willingness to adhere to a 6-month TC protocol.”
BackgroundThe Effect of Art Therapy on Cognitive Performance of Hispanic/Latino Older Adults
Alders, A., & Levine‐Madori, L. (2010) · Art Therapy · doi:10.1080/07421656.2010.10129661 · Cited by 39
The Health and Retirement Study
Stoiko, R. R. (2014) · The International Journal of Aging and Human Development · doi:10.1177/0091415015574186 · Cited by 40
Brainerd, C. J., Reyna, V. F., Petersen, R. C., Smith, G. E., Kenney, A. E., Gross, C. J., Taub, E. S., Plassman, B. L., & Fisher, G. G. (2013) · Neuropsychology · doi:10.1037/a0030855 · Cited by 36
“Method Participants The full details of the ADAMS subject sample have been provided in several publications (e.g., Langa et al., 2005; Plassman et al., 2007, 2008) and, therefore, will not be extensively reprised here.”
MethodSelf-citationRecent developments in longitudinal studies of aging in the United States
Hauser, R. M., & Weir, D. R. (2010) · Demography · doi:10.1353/dem.2010.0012 · Cited by 41
“Similar observations apply to the ADAMS spin-off of HRS, which differs from most studies of dementia because it pertains to a representative sample of such persons (Langa, et al. 2005; Plassman et al. 2007 ).”
MethodSelf-citationCommon-sense beliefs about the prevention of Alzheimer's disease
Anderson, L. N., McCaul, K. D., & Langley, L. K. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.569478 · Cited by 35
“Given the high prevalence of AD in the population (e.g., 24% of adults over age 80 will have AD; Plassman et al., 2007), the level of exposure to AD for our younger adults is not overly surprising.”
BackgroundAnderson, E. D., Wahoske, M. L., Huber, M. J., Norton, D., Li, Z., Koscik, R. L., Umucu, E., Johnson, S. C., Jones, J. E., Asthana, S., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.05.003 · Cited by 44
“The prevalence of Alzheimer’s disease (AD) is rising, creating an urgency to develop effective interventions [1,2].”
BackgroundRacial/Ethnic Differences in Health‐Related Quality of Life in Persons With and Without Dementia
Hayes‐Larson, E., Mobley, T. M., Gilmore‐Bykovskyi, A. L., Shaw, C. L., Karlamangla, A. S., Manly, J. J., & Mayeda, E. R. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16908 · Cited by 38
Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages
Drzezga, A. E. (2009) · Behavioural Neurology · doi:10.1155/2009/276026 · Cited by 45
Neurodegenerative Disorders and Sleep
Malhotra, R. K. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.02.009 · Cited by 40
Effects of acupuncture on Chinese medicine syndromes of vascular dementia
Shi, G., Liu, C., Guan, W., Wang, Z., Wang, L., Chuan, X., Li, Z., Li, Q., & Wang, L. (2013) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1323-4 · Cited by 40
Verbal Naming Test for Use with Older Adults: Development and Initial Validation
Yochim, B. P., Beaudreau, S. A., Fairchild, J. K., Yutsis, M. V., Raymond, N. C., Friedman, L., & Yesavage, J. A. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715000120 · Cited by 38
“The prevalence of dementia in adults age 71 and older has been estimated to be 14%, with rates increasing to 24% for individuals age 80–89 and 37% for those individuals age 90 and older (Plassman et al., 2007).”
BackgroundFactors Associated With African American and White Elders' Participation in a Brain Donation Program
Jefferson, A. L., Lambe, S. A., Cook, E., Pimontel, M. A., Palmisano, J. N., & Chaisson, C. E. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f3e059 · Cited by 39
“(2) The Intrinsic Religiousness Motivation Survey consisted of the 10-item Intrinsic Religious Motivation Scale(24) (eg, “Nothing is as important to me as serving God as best I know how”) plus 3 questions from the Brief Multidimensional Measure of Religiousness/ Spirituality(25) (eg, “To what extent do you consider yo…”
BackgroundMethodAssociation Between Sleep Quality and Cognitive Impairment Among Chinese Nonagenarians/Centenarians
Chang-Quan, H., Bi-Rong, D., & Yan, Z. (2012) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e3182570f2e · Cited by 36
“Both sleep disorders and cognitive impairment are associated with degenerative neurologic disorders (Dauvilliers, 2007; Plassman et al., 2007; Wu and Swaab, 2007), and cognitive impairment, sleep complaints, and sleep-related problems increase with age (Bastos Leite et al.”
BackgroundKhan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 38
Prevalence of Depression and Cognitive Impairment in Older Adult Emergency Medical Services Patients
Shah, M. N., Jones, C. M. C., Richardson, T. M., Conwell, Y., Katz, P. R., & Schneider, S. M. (2011) · Prehospital Emergency Care · doi:10.3109/10903127.2010.514093 · Cited by 38
“Depressed, ≥10 points 55 (13%) 47 (11%) Score—median (IQR) 3 (1, 6) 3 (1, 6) N = 415 N = 415 Cognitive impairment (SIS) Impaired, >2 errors 46 (11%) 32 (8%) N = 423 N = 421 Patients admitted to the hospital Depression (PHQ-9) Depressed, ≥10 points 43 (18%) 39 (18%) Score—median (IQR) 4 (1, 7) 4 (2, 8) N = 242 N = 218…”
Consensus statement on dementia education and training in Europe
Tsolaki, M., Papaliagkas, V., Anogianakis, G., Bernabei, R., Emre, M., Frolich, L., Visser, P. J., Michel, J.-P., Pirttila, T., Olde Rikkert, M., et al. (2010) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0238-z · Cited by 36
“This disease affected approximately 24 million individuals worldwide in the year 2002 (3), 25 million in the year 2005, and is expected to be over 80 million cases by 2040 (4).”
Dupuis, K., Reed, M., Lemke, U., & Pichora-Fuller, M. (2013) · Seminars in Hearing · doi:10.1055/s-0033-1356643 · Cited by 35
“The model estimates are consistent with data from the United States collected around the same time indicating that prevalence of dementia increasedwith age, from 5% of those aged 71 to 79 years to 37% of those aged 90 and older, with an overall prevalence of 14% for all individuals aged 71 and older.(53) A recent revi…”
ResultSildenafil treatment of vascular dementia in aged rats
Venkat, P., Chopp, M., Zacharek, A., Cui, C., Landschoot‐Ward, J., Yu, Q., Chen, Z., & Chen, J. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.015 · Cited by 38
Xu, W., Lau, Z. W. X., Fülöp, T., & Larbi, A. (2020) · Cells · doi:10.3390/cells9051181 · Cited by 44
Nguyen, D. H., Cunningham, J. T., & Sumien, N. (2020) · GeroScience · doi:10.1007/s11357-020-00263-4 · Cited by 38
Precise or Imprecise Probabilities? Evidence from Survey Response Related to Late-Onset Dementia
Giustinelli, P., Manski, C. F., & Molinari, F. (2021) · Journal of the European Economic Association · doi:10.1093/jeea/jvab023 · Cited by 37
Sie, Y.-Y., Chen, L., Li, C.-J., Yuan, Y.-H., Hsiao, S.-H., Lee, M., Wang, C., & Hou, W. (2023) · Antioxidants · doi:10.3390/antiox12071362 · Cited by 38
“Alzheimer’s disease (AD), the main dementia type accounting for over 70% of the entire dementia population [1], clinically features a gradual and progressive decline in memory and executive function (such as short-term memory dysfunctions in organizing and expressing thoughts), the loss of the ability to retain new in…”
BackgroundAmyloid-plaque imaging in early and differential diagnosis of dementia
Drzezga, A. E. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0330-9 · Cited by 40
“Regarding the fact that the elderly population (those aged 65 years or older) in the USA is expected to duplicate from approximately 35 million today to more than 70 million by 2030, the incidence of AD is expected to approach nearly a million people per year, with a total estimated prevalence of 11–16 million persons…”
BackgroundDowner, B. G., García, M. A., Saenz, J. L., Markides, K. S., & Wong, R. (2017) · Research on Aging · doi:10.1177/0164027517701447 · Cited by 37
“Over 5 million adults aged 65 and older in the United States are living with AD (Hebert, Weuve, Scherr, & Evans, 2013), and nearly one in six adults aged 71 and older are living with dementia (Plassman et al., 2007).”
BackgroundAfrican American exome sequencing identifies potential risk variants at Alzheimer disease loci
N'Songo, A., Carrasquillo, M. M., Wang, X., Burgess, J. D., Nguyen, T., Asmann, Y. W., Serie, D. J., Younkin, S. G., Allen, M., Pedraza, O., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000141 · Cited by 36
Patients Who Share Transparent Visit Notes With Others: Characteristics, Risks, and Benefits
Jackson, S. L., Mejilla, R., Darer, J. D., Oster, N. V., Ralston, J. D., Leveille, S. G., Walker, J., Delbanco, T., & Elmore, J. G. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3363 · Cited by 36
“As Americans age, with more patients with comorbid complex conditions and the prevalence of dementia likely to triple by 2050 [3,4], provision of care by family members and other close relations will likely become increasingly common.”
Rocha, V., Marques, A. S. P. D. D., Pinto, M., de Sousa, L. X. M., & de Figueiredo, D. M. P. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2012.742677 · Cited by 45
“between dementia and the increased loss of functionality [40,59] and consequently, decline in activities and participation [50].”
BackgroundStewart, T. V., Loskutova, N., Galliher, J. M., Warshaw, G. A., Coombs, L., Staton, E. W., Huff, J., & Pace, W. D. (2014) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2014.02.120284 · Cited by 39
“older US adults (about 40 million people 65 years old) and 44% of US adults 85 years old have dementia.(2) The burden of suffering from dementia is great for patients, their families, and the larger community because of increasing personal dependency and depression as well as family/caregiver stress, anxiety, and depr…”
BackgroundCerebral vasomotor reactivity in neurodegenerative diseases
Smoliński, Ł., & Członkowska, A. (2016) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2016.07.011 · Cited by 42
“[6] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al.”
Soleimani, R., Shokrgozar, S., Fallahi, M., Kafi, H., & Kiani, M. (2018) · Journal of Medicine and Life · doi:10.25122/jml-2018-0017 · Cited by 39
“2%, ranging from 16% (71–79 years) to 39% (≥90 years) [22].”
Kodishala, C., Hulshizer, C. A., Kronzer, V. L., Davis, J. M., Ramanan, V. K., Vassilaki, M. E., Mielke, M. M., Crowson, C. S., & Myasoedova, E. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.220200 · Cited by 37
“However, we believe that the following elements of the study design help to minimize this limitation: (1) patients were scrutinized for their comorbidities in a similar way during their regular rheumatology follow-ups and through their referrals to other specialties including neurology, and (2) regular follow-ups with…”
BackgroundAssessing and managing frailty in emergency laparotomy: a WSES position paper
Tian, B. W. C. A., Stahel, P. F., Picetti, E., Campanelli, G., Saverio, S. D., Moore, E. E., Bensard, D. D., Sakakushev, B. E., Galante, J. M., Fraga, G. P., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00506-7 · Cited by 40
Evaluation of suspected dementia.
Simmons, B. B., Hartmann, B., & DeJoseph, D. (2011) · PubMed · Cited by 36
Feasibility of Machine-Based Prompting to Assist Persons With Dementia
Bewernitz, M., Mann, W. C., Dasler, P. J., & Belchior, P. D. C. (2009) · Assistive Technology · doi:10.1080/10400430903246050 · Cited by 43
“Nearly 14% of people over age 71 have some form of dementia, with the prevalence increasing to nearly 40% of those over age 90 ( Plassman et al, 2007 ).”
BackgroundWeijenberg, R. A. F., Lobbezoo, F., Knol, D. L., Tomassen, J., & Scherder, E. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-26 · Cited by 42
Can peripheral leukocytes be used as Alzheimer’s disease biomarkers?
Rezai-Zadeh, K. P., Gate, D., Szekely, C. A., & Town, T. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.118 · Cited by 40
“2 million by 2050 [2,3].”
Cary, B. P., Brooks, A. F., Fawaz, M. V., Drake, L. R., Desmond, T. J., Sherman, P. S., Quesada, C., & Scott, P. J. H. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00319 · Cited by 40
In vivo network models identify sex differences in the spread of tau pathology across the brain
Shokouhi, S., Taylor, W. D., Albert, K., Kang, H., Newhouse, P. A., & Initiative, T. A. D. N. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12016 · Cited by 35
Understanding Dysphagia in Dementia: The Present and the Future
Rogus‐Pulia, N. M., Malandraki, G. A., Johnson, S. C., & Robbins, J. (2015) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-015-0078-1 · Cited by 37
The Age of Onset of Anxiety Disorders
Legerstee, J. S., Dierckx, B., Utens, E. M. W. J., Verhulst, F. C., Zieldorff, C., Dieleman, G. C., & de Lijster, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-72619-9_7 · Cited by 38
Dementia-related psychosis and the potential role for pimavanserin
Cummings, J. L., Devanand, D. P., & Stahl, S. M. (2020) · CNS Spectrums · doi:10.1017/s1092852920001765 · Cited by 37
Brucki, S. M. D., & Nitríni, R. (2014) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642014dn84000007 · Cited by 39
Cognitive Impairment among Older Adults in the Emergency Department.
Hirschman, K. B., Paik, H. H., Pines, J. M., McCusker, C. M., Naylor, M. D., & Hollander, J. E. (2011) · PubMed · Cited by 35
Brenowitz, W. D., Kukull, W. A., Beresford, S. A. A., Monsell, S. E., & Williams, E. C. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000020 · Cited by 42
Prevalence of Dementia in Elderly Patients with Hip Fracture
Yiannopoulou, K. G., Anastasiou, I. P., Ganetsos, T. K., Efthimiopoulos, P., & Papageorgiou, S. G. (2012) · Hip International · doi:10.5301/hip.2012.9229 · Cited by 35
Sokolovič, L., Hofmann, M., Mohammad, N., & Kukolja, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1267434 · Cited by 41
Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
Johansen, K. K., White, L. R., Sando, S. B., & Aasly, J. O. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.015 · Cited by 41
“The average number of demented cases in the general population, all types included, is about ten times higher than the prevalence of PD [13,14]; however, there is considerable disagreement on the prevalence of DLB, where estimates between <1% and 5% in the general population, and <1% up to 30% in the dementia populati…”
BackgroundTurner, T. H., Horner, M. D., VanKirk, K. K., Myrick, H., & Tuerk, P. W. (2012) · Telemedicine and e-Health · doi:10.1089/tmj.2011.0272 · Cited by 33
“Moreover, up to 20% of older Americans have a mental health disorder,(18) with about 15% experiencing some type of dementia.(19) The development of teleneuropsychology can help providers service the increasing demand for assessments and intervention.”
Viaña, J. N. M., Vickers, J. C., Cook, M. J., & Gilbert, F. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.001 · Cited by 35
Mental Disorders Among Elderly People in Baghdad, Iraq, 2017
Ibrahim, A. A., Lami, F., Al-Rudainy, R., & Khader, Y. S. (2019) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/0046958019845960 · Cited by 34
Medical Decision-Making in Oncology for Patients Lacking Capacity
Marron, J. M., Kyi, K., Appelbaum, P. S., & Magnuson, A. M. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280279 · Cited by 39
Ribeiro, P. C. C., Lopes, C. D. S., & Lourenço, R. A. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345984 · Cited by 36
Bain, L. J., Jedrziewski, K., Morrison‐Bogorad, M., Albert, M., Cotman, C. W., Hendrie, H. C., & Trojanowski, J. Q. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.08.006 · Cited by 35
“[1] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al.”
BackgroundShi, G., Liu, C., Li, Q., Hong, Z. H. U., & Wang, L. (2012) · 中医杂志:英文版 · doi:10.1016/s0254-6272(13)60011-4 · Cited by 34
Epidemiology of dementia and its burden in the city of Kolkata, India
Banerjee, T. K., Dutta, S., Das, S., Ghosal, M. K., Ray, B. K., Biswas, A., Hazra, A., Chaudhuri, A., Paul, N., & Das, S. K. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4499 · Cited by 34
“In contrast, dementia is much more prevalent in Europe, North, and South America (Ferri et al., 2005; Plassman et al., 2007; Murray et al., 2010; Rizzi et al., 2014).”
BackgroundZhou, H., Sabbagh, M. N., Wyman, R., Liebsack, C., Kunik, M. E., & Najafi, B. (2016) · Gerontology · doi:10.1159/000452309 · Cited by 35
CLINICAL EXOME SEQUENCING IN DEMENTIAS: A PRELIMINARY STUDY
Zalar, B., Maver, A., Kovanda, A., Peterlin, A., & Peterlin, B. (2018) · Psychiatria Danubina · doi:10.24869/psyd.2018.216 · Cited by 35
Chan, S., & Elbel, B. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1000 · Cited by 33
Ge, S., Pan, W., Wu, B., Plassman, B. L., Dong, X., & McConnell, E. S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1092297 · Cited by 36
Self-citationChen, X., Zimmerman, S. I., Potter, G. G., Sloane, P. D., Cohen, L. W., & Reed, D. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14772 · Cited by 34
Self-citationTsolaki, M., Γκιόκα, Μ., Verykouki, E., Galoutzi, N., Kavalou, E., & Pattakou-Parasyri, V. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517698789 · Cited by 42
“2%), probably due to the different methodology.(63,64) A recent review in China, which included 89 studies and 340 247 participants, indicated that the prevalence of dementia in 2010 was 2.”
Ye, Q., & Bai, F. (2018) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000080 · Cited by 36
Kuchibhatla, M. N., Hunter, J. C., Plassman, B. L., Lutz, M. W., Casanova, R., Saldana, S. J., & Hayden, K. M. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1594169 · Cited by 34
Self-citationDiagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Jutkowitz, E., Bynum, J., Mitchell, S. L., Cocoros, N. M., Shapira, O., Haynes, K., Nair, V. P., McMahill‐Walraven, C. N., Platt, R. G., & McCarthy, E. P. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12048 · Cited by 35
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
Palta, P., Rippon, B., Tahmi, M., Pardo, M., Johnson, A. S., Tomljanovic, Z., He, H., Laing, K. K., Razlighi, Q. R., Teresi, J. A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.007 · Cited by 33
Hayes‐Larson, E., Mobley, T. M., Mungas, D., Seamans, M. J., Glymour, M. M., Gilsanz, P., DeCarli, C. S., Whitmer, R. A., & Mayeda, E. R. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12522 · Cited by 34
Association between sepsis and dementia
Kao, L., Sheu, J., Lin, H., Tsai, M.-C., & Chung, S. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.035 · Cited by 37
“Studies in the USA and Europe have both shown high rates of dementia in the elderly [3,4].”
BackgroundMild cognitive impairment: a history and the state of current diagnostic criteria
Gerstenecker, A. T., & Mast, B. T. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214002270 · Cited by 36
Validation and diagnostic accuracy of the Alzheimer's questionnaire
Malek‐Ahmadi, M. H., Davis, K. J., Belden, C. M., Laizure, B., Jacobson, S. A., Yaari, R., Singh, U., & Sabbagh, M. N. (2012) · Age and Ageing · doi:10.1093/ageing/afs008 · Cited by 33
“Given the expected increase in Alzheimer’s disease (AD) prevalence in the USA [1] many clinicians will be faced with the prospect of evaluating many individuals for possible cognitive impairment.”
BackgroundBetaine reverses the memory impairments in a chronic cerebral hypoperfusion rat model
Nie, C., Nie, H., Zhao, Y., Wu, J., & Zhang, X. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.019 · Cited by 35
Colenda, C. C., Legault, C., Rapp, S. R., DeBon, M. W., Hogan, P. E., Wallace, R. B., Hershey, L. A., Ockene, J. K., Whitmer, R., Phillips, L. S., et al. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c65864 · Cited by 33
“20 Alcohol abuse (13) 0 (0) 5 (2) 2 (1) Fisher’s exact — 0.”
Self-citationWeir, D. R., Wallace, R. B., Langa, K. M., Plassman, B. L., Wilson, R. S., Bennett, D. A., Duara, R., Loewenstein, D., Ganguli, M., & Sano, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.11.004 · Cited by 35
“[10] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al.”
BackgroundSelf-citationHigh Rates of Native Hawaiian and Older Japanese Adults Hospitalized with Dementia in Hawai‘i
Sentell, T. L., Valcour, N., Ahn, H. J., Miyamura, J., Nakamoto, B. K., Chow, D. C., Masaki, K., Seto, T. B., Chen, J. J., & Shikuma, C. M. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13182 · Cited by 32
“4 million individuals in the United States have dementia.(1) It is estimated that the number of dementia cases worldwide will increase to 80 to 110 million by 2040.”
BackgroundChen, M., Chen, K., Chang, C.-L., Chang, Y., Cheng, Y., & Huang, H. (2016) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000518 · Cited by 32
“19% of adults older than 80 years have dementia.(3) In Taiwan, 230,000 people have dementia, and 220,000 of them are adults older than 65 years, which accounts for 8.”
BackgroundXu, H. J., Wang, Y., Yuan, Y., Zhang, X., Zuo, X., Cui, L., Liu, Y., Chen, W., Su, N., Wang, H., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s165618 · Cited by 33
Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia
Liu, Y., Chan, D. K. Y., Thalamuthu, A., Wen, W. X., Jiang, J., Paradise, M., Lee, T., Crawford, J. D., Wong, M. W. K., Xu, Y. H., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.001 · Cited by 36
Age related hearing loss and cognitive impairment - a current perspective
Swain, S. K. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20205863 · Cited by 32
“The prevalence of dementia is from approximately 5% in 71 to 79 years of age to approximately 37% in 90 years of age or above with an overall prevalence of approximately 14% in above 70 years of age.(8) In case of dementia in elderly age group, it increases from approximately 5% at 71 to 79 years to approximately 37%…”
BackgroundTen year cumulative incidence of dementia after late onset epilepsy of unknown etiology
Keret, O., Brauner, R., Benninger, F., & Glik, A. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.01.030 · Cited by 35
Espinoza, S. E., Khosla, S., Baur, J. A., de Cabo, R., & Musi, N. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad034 · Cited by 34
Yang, H., Lyutvinskiy, Y., Soininen, H. S., & Zubarev, R. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110626 · Cited by 37
“This is because there seems to be higher prevalence of AD in women [16, 17], although this could also be linked to higher longevity of women [18].”
Roberts, J. S., & Tersegno, S. M. (2010) · Future Neurology · doi:10.2217/fnl.10.31 · Cited by 31
“Females have a higher prevalence of AD than men [7], with debate regarding whether this difference is largely attributable to longer life expectancy among females.”
Background
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.